Breaking News, Financial News

Financial Report: Kendle 3Q

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Kendle 3Q Revenues: $181.1 million (+27%) 3Q Earnings: $11.0 million  (+189%) YTD Revenues: $517.3 million (+25%) YTD Earnings: $24.4 million (+98%) Comments: Early stage revenues were $11.2 million (+138%). Late stage revenues were $110.9 million (+19%). The acquisition of DecisionLine Clinical Research Corp. accounted for 6% of growth in the quarter. New business awards totaled a record $212 million in the quarter, (+21%). Contract cancellations totaled $38 million or 18% of s...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters